Wird geladen...

Risk of Nephrogenic Systemic Fibrosis Is Low in Patients With Chronic Liver Disease Exposed to Gadolinium-Based Contrast Agents

PURPOSE: To determine the risk of nephrogenic systemic fibrosis (NSF) in a cohort of patients with chronic liver disease. MATERIALS AND METHODS: This retrospective, Institutional Review Board (IRB)-approved, Health Insurance Portability and Accountability Act (HIPAA)-compliant study was performed at...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Magn Reson Imaging
Hauptverfasser: Smorodinsky, Emmanuil, Ansdell, David S., Foster, Zeke W., Mazhar, Sameer M., Cruite, Irene, Wolfson, Tanya, Sugay, Sebastian B., Iussich, Gabriella, Shiehmorteza, Masoud, Kono, Yuko, Kuo, Alexander, Sirlin, Claude B.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2014
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5935244/
https://ncbi.nlm.nih.gov/pubmed/24811860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmri.24650
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!